Crowdonomics
WatchlistPortfolio
All companies
Imago Rehab logo

Imago Rehab

Unknown

Imago Rehab Inc.

Healthcare · Founded 2020

Visit website

AI & robotics for the $210B rehab industry

Post-money valuation ⓘ
$12.7M
As of Jul 2025 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$4,369,703
Crowd $702K · Private $3.7M · 3 rounds since 2021
Latest share price
$1.0053
Reg CF · Preferred Stock · Dec 2024 offering price

Financials

FY2022–FY2023 · from SEC filings · hover any figure for its source
$76K
−$635K
2022
$107K
−$1.4M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$75,887
$107,135
Cost of goods sold
$42,341
$69,052
Gross margin
44%
36%
Net income
-$634,523
-$1,350,533
Taxes paid
$0
$0
Balance sheet
Cash
$2,291,907
$1,122,731
Accounts receivable
$10,721
$23,289
Total assets
$2,450,060
$1,158,291
Short-term debt
$30,129
$98,887
Long-term debt
$0
$0
Total liabilities
$30,129
$98,887
Other
Headcount
—
10

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$12.0M
pre-money
Reg CF · Preferred · Dec 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Preferred Stock · Dec 2024Closedvia WeFunder
Raised $701.6K / $1.2MInvestors 159Post-money $12.7M
Rule 506(b) · Equity · Jun 2024Closed
Raised $250KInvestors 1
Rule 506(b) · Equity · Dec 2021Closed
Raised $3.4MInvestors 44

Team

6 people
Conor WalshFounder
Cofounder and Board Member
Kristin Noelle NuckolsFounder
Cofounder, Chief Clinical Officer
James Christopher Dugan
CEO
Gene Tacy
COO & President
Paul Pedevillano
CFO
Arunas A. Chesonis
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 2 annual reports (FY2024–FY2025)

Missing: 2024, 2025

159 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C/AApr 15, 20250001670254-25-000363
    EDGAR
  • Form CSep 23, 20240001670254-24-000949
    EDGAR
  • Form DJul 8, 20240001567619-24-000344
    EDGAR
  • Form DApr 20, 20230001567619-23-005716
    EDGAR
Source: ManualCIK 0001974063Share price $1.0053

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.